RCTs with new antiepileptic drugs in children: A systematic review of monotherapy studies and their methodology

Epilepsy Research

Volumn 91, Issue 1, 2010, Pages 1-9

  Weijenberg, Amerins ^a   Offringa, Martin ^b   Brouwer, Oebele F ^a   Callenbach, Petra M C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Efficacy; Methodology; RCT; Safety; Study design

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PLACEBO; TOPIRAMATE; VALPROIC ACID;

ABDOMINAL PAIN; ANOREXIA; BENIGN CHILDHOOD EPILEPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIZZINESS; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FATIGUE; FOLLOW UP; GINGIVA HYPERPLASIA; HEADACHE; HUMAN; INFECTION; MEDICAL DECISION MAKING; MONOTHERAPY; NAUSEA; OUTCOME ASSESSMENT; PHARYNGITIS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SIDE EFFECT; SOMNOLENCE; STUDY DESIGN; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VALIDATION STUDY; WEIGHT GAIN;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUGS, INVESTIGATIONAL; EPILEPSY; FOLLOW-UP STUDIES; HUMANS; INFANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77956010941     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.07.004     Document Type: Review

References (45)

1. Aikia M., Jutila L., Salmenpera T., Mervaala E., Kalviainen R. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies. Epilepsia 2006, 47:1121-1127.
2. Arroyo S., Dodson W.E., Privitera M.D., Glauser T.A., Naritoku D.K., Dlugos D.J., Wang S., Schwabe S.K., Twyman R.E. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol. Scand. 2005, 112:214-222.
3. Arroyo S., Squires L., Wang S., Twyman R. Topiramate: effective as monotherapy in dose-response study in newly diagnosed epilepsy. Epilepsia 2002, 43(Suppl. 7):241.
4. Beydoun A., Sachdeo R.C., Kutluay E., McCague K., D'Souza J. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. Epilepsia 2003, 44:1160-1165.
5. Beydoun A., Sachdeo R.C., Rosenfeld W.E., Krauss G.L., Sessler N., Mesenbrink P., Kramer L., D'Souza J. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 2000, 54:2245-2251.
6. Biton V., Levisohn P., Hoyler S., Vuong A., Hammer A.E. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial. J. Child Neurol. 2003, 18:133-139.
7. Biton V., Mirza W., Montouris G., Vuong A., Hammer A.E., Barrett P.S. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001, 56:172-177.
8. Bourgeois B., Brown L.W., Pellock J.M., Buroker M., Greiner M., Garofalo E.A., Schimschock J.R., Griesemer D., Bebin M.E., Murphy J.V. Gabapentin (Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS): a 36-week, double-blind, placebo-controlled study. Epilepsia 1998, 39(Suppl. 6):163.
9. Callenbach P.M.C., Arts W.F.M., ten Houten R., Augustijn P., Gunning W.B., Peeters E.A.J., Weber A.M., Stroink H., Geerts Y., Geerts A.T., Brouwer O.F. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Eur. J. Paediatr. Neurol. 2008, 12:321-327.
10. Carpay J.A., Aldenkamp A.P., van Donselaar C.A. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure 2005, 14:198-206.
11. Chadwick D.W., Anhut H., Greiner M.J., Alexander J., Murray G.H., Garofalo E.A., Pierce M.W. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 1998, 51:1282-1288.
12. Chung A.M., Eiland L.S. Use of second-generation antiepileptic drugs in the pediatric population. Paediatr. Drugs 2008, 10:217-254.
13. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22:489-501.
14. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
15. Coppola G., Auricchio G., Federico R., Carotenuto M., Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia 2004, 45:1049-1053.
16. Coppola G., Franzoni E., Verrotti A., Garone C., Sarajlija J., Felicia Operto F., Pascotto A. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. Brain Dev. 2007, 29:281-284.
17. Duchowny M., Pellock J.M., Graf W.D., Billard C., Gilman J., Casale E., Womble G., Risner M., Manasco P. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group. Neurology 1999, 53:1724-1731.
18. Dulac O. Issues in paediatric epilepsy. Acta Neurol. Scand. 2005, (Suppl. 182):9-11.
19. European Medicines Agency (Committee for Medicinal Products for Human use) Guideline on Data Monitoring Committees 2005, EMEA/CHMP/EWP/5872/03 Corr.
20. Fernandes R.M., van der Lee J.H., Offringa M. A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials. BMC Pediatr. 2009, 9:77.
21. Frank L.M., Enlow T., Holmes G.L., Manasco P., Concannon S., Chen C., Womble G., Casale E.J. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999, 40:973-979.
22. Gilliam F.G., Veloso F., Bomhof M.A., Gazda S.K., Biton V., Ter Bruggen J.P., Neto W., Bailey C., Pledger G., Wu S.C. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003, 60:196-202.
23. Glauser T.A., Dlugos D.J., Dodson W.E., Grinspan A., Wang S., Wu S.C. Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents. J. Child Neurol. 2007, 22:693-699.
24. Glauser T.A., Nigro M., Sachdeo R., Pasteris L.A., Weinstein S., Abou-Khalil B., Frank L.M., Grinspan A., Guarino T., Bettis D., Kerrigan J., Geoffroy G., Mandelbaum D., Jacobs T., Mesenbrink P., Kramer L., D'Souza J. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology 2000, 54:2237-2244.
25. Guerreiro M.M., Vigonius U., Pohlmann H., de Manreza M.L., Fejerman N., Antoniuk S.A., Moore A. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997, 27:205-213.
26. Huang T.S., Zhu J.L., Li B., Hu Y., Chen L., Liao J.X. Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children. Zhongguo Dang. Dai Er. Ke. Za Zhi. 2009, 11:653-655.
27. Ingwersen S.H., Pedersen P.C., Groes L., Nielsen K.K., Aarons L. Population pharmacokinetics of tiagabine in epileptic patients on monotherapy. Eur. J. Pharm. Sci. 2000, 11:247-254.
28. Jensen P.K. Felbamate in the treatment of refractory partial-onset seizures. Epilepsia 1993, 34(Suppl. 7):S25-S29.
29. Kang H.C., Eun B.L., Wu L.C., Ku M.H., Kim J.S., Wook K.D., Soo L.J., Young C.K., Ho C.B., Sook S.E., Chae P.J., Lim K., Hye H.E., Ho S.D., Dong K.H. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia 2007, 48:1716-1723.
30. Lindberger M., Alenius M., Frisen L., Johannessen S.I., Larsson S., Malmgren K., Tomson T. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment. Epilepsia 2000, 41:1289-1295.
31. Nieto-Barrera M., Brozmanova M., Capovilla G., Christe W., Pedersen B., Kane K., O'Neill F. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 2001, 46:145-155.
32. Noachtar S., Andermann E., Meyvisch P., Andermann F., Gough W.B., Schiemann-Delgado J. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008, 70:607-616.
33. Perucca E., Tomson T. Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications. Epilepsy Res. 1999, 33:247-262.
34. Privitera M.D., Brodie M.J., Mattson R.H., Chadwick D.W., Neto W., Wang S. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol. Scand. 2003, 107:165-175.
35. Resendiz-Aparicio J.C., Rodriguez-Rodriguez E., Contreras-Bernal J., Ceja-Moreno H., Barragan-Perez E., Garza-Morales S., Malagon-Valdez J., Ortega-Gonzalez F. A randomised open trial comparing monotherapy with topiramate versus carbamazepine in the treatment of paediatric patients with recently diagnosed epilepsy. Rev. Neurol. 2004, 39:201-204.
36. Sachdeo R., Beydoun A., Schachter S., Vazquez B., Schaul N., Mesenbrink P., Kramer L., D'Souza J. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 2001, 57:864-871.
37. Sankar R., Ramsay E., McKay A., Hulihan J., Wiegand F. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice. Epilepsy Behav. 2009, 15:506-512.
38. Schachter S.C., Vazquez B., Fisher R.S., Laxer K.D., Montouris G.D., Combs-Cantrell D.T., Faught E., Willmore L.J., Morris G.L., Ojemann L., Bennett D., Mesenbrink P., D'Souza J., Kramer L. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 1999, 52:732-737.
39. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412.
40. Sethi A., Chandra D., Puri V., Mallika V. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. Neurol. India 2002, 50:359-363.
41. Siegel H., Kelley K., Stertz B., Reeves-Tyer P., Flamini R., Malow B., Gaillard W.D., Ko D., Theodore W.H. The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome. Epilepsy Res. 1999, 34:91-97.
42. Trudeau V., Myers S., LaMoreaux L., Anhut H., Garofalo E., Ebersole J. Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J. Child Neurol. 1996, 11:470-475.
43. Uijl S.G., Uiterwaal C.S., Aldenkamp A.P., Carpay J.A., Doelman J.C., Keizer K., Vecht C.J., de Krom M.C., van Donselaar C.A. A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with anti-epileptic drugs. Seizure 2006, 15:242-248.
44. Verrotti A., Cerminara C., Domizio S., Mohn A., Franzoni E., Coppola G., Zamponi N., Parisi P., Iannetti P., Curatolo P. Levetiracetam in absence epilepsy. Dev. Med. Child Neurol. 2008, 50:850-853.
45. Wheless J.W., Neto W., Wang S. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. J. Child Neurol. 2004, 19:135-141.